R. Visentin

发表

First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas

L. Magni, C. Cobelli, B. Kovatchev, 2014, Diabetes Care.

Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home

L. Magni, C. Cobelli, B. Kovatchev, 2016, Diabetes Care.

Feasibility of Outpatient Fully Integrated Closed-Loop Control

Howard C. Zisser, F. Doyle, C. Cobelli, 2013, Diabetes Care.

Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models

Josep Vehí, Roberto Visentin, Martina Vettoretti, 2017, PloS one.

Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes

Shelly K McCrady-Spitzer, C. Cobelli, B. Kovatchev, 2017, The Journal of clinical endocrinology and metabolism.

Aryloxyphenoxypropionate in association with others herbicides in controlling weedy rice and barnyardgrass

R. Visentin, N. Guerra, A. M. O. Neto, 2020 .

In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes

C. Cobelli, T. Klabunde, C. Dalla Man, 2020, Diabetes technology & therapeutics.

Hepatic insulin sensitivity in healthy and prediabetic subjects: from a dual- to a single-tracer oral minimal model.

C. Cobelli, R. Rizza, A. Basu, 2015, American journal of physiology. Endocrinology and metabolism.

Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus

Claudio Cobelli, Roberto Visentin, Dario Iafusco, 2017, Journal of diabetes science and technology.

The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day

Claudio Cobelli, Roberto Visentin, Martina Vettoretti, 2018, Journal of diabetes science and technology.

Modeling Subcutaneous Absorption of U100 and U300 Insulin Glargine in Type 1 Diabetes

C. Cobelli, T. Klabunde, C. D. Man, 2017 .

Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe

Claudio Cobelli, Giordano Lanzola, Lalo Magni, 2016, Diabetes Care.

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator

Claudio Cobelli, Roberto Visentin, Chiara Dalla Man, 2016, Diabetes technology & therapeutics.

Mechanisms of hyperinsulinaemia in apparently healthy non-obese young adults: role of insulin secretion, clearance and action and associations with plasma amino acids

C. Dalla Man, C. S. Shaw, R. Visentin, 2019, Diabetologia.

Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes

L. Magni, C. Cobelli, G. Lanzola, 2015, Diabetes, obesity & metabolism.

Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide

C. Cobelli, T. Klabunde, R. Visentin, 2021, Diabetes, obesity & metabolism.

Physiological models for artificial pancreas development

C. Cobelli, A. Basu, R. Visentin, 2019, The Artificial Pancreas.

Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results

Claudio Cobelli, Lalo Magni, Roberto Visentin, 2018, IEEE Transactions on Biomedical Engineering.

Randomized Controlled Trial of a MUFA or Fiber-Rich Diet on Hepatic Fat in Prediabetes

C. Cobelli, W. Kremers, J. Port, 2017, The Journal of clinical endocrinology and metabolism.

Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions

Claudio Cobelli, Giordano Lanzola, Lalo Magni, 2017 .

2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.

Claudio Cobelli, Giordano Lanzola, Lalo Magni, 2015, The lancet. Diabetes & endocrinology.

Determinants of hepatic insulin clearance - results from a Mendelian Randomization study.

F. Schick, N. Stefan, J. Machann, 2021, Metabolism: clinical and experimental.

In Silico Cloning of Target Type 2 Diabetes Population for Treatments Development and Decision Support*

Roberto Visentin, Michele Schiavon, Chiara Dalla Man, 2020, 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC).

Parental evaluation of a telemonitoring service for children with Type 1 Diabetes

C Cobelli, G Lanzola, S Quaglini, 2017, Journal of telemedicine and telecare.

One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator

Claudio Cobelli, Roberto Visentin, Chiara Dalla Man, 2016, IEEE Transactions on Biomedical Engineering.

Dual glucagon‐like peptide‐1 receptor/glucagon receptor agonist SAR425899 improves beta‐cell function in type 2 diabetes

C. Cobelli, T. Klabunde, C. Dalla Man, 2019, Diabetes, obesity & metabolism.

The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial.

C. Cobelli, B. Kovatchev, R. Visentin, 2014 .

A Model of Acetaminophen Pharmacokinetics and its Effect on Continuous Glucose Monitoring Sensor Measurements

Giada Acciaroli, Roberto Visentin, Martina Vettoretti, 2018, 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).